These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4293602)

  • 1. In vivo interaction of 4-nitroquinoline-1-oxide and its derivatives with DNA.
    Matsushima T; Kobuna I; Sugimura T
    Nature; 1967 Nov; 216(5114):508. PubMed ID: 4293602
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of 4-nitroquinoline-1-oxide, a carcinogen. 3. An enzyme catalyzing the conversion of 4-nitroquinoline-1-oxide to 4-hydroxyaminoquinoline-1-oxide in rat liver and hepatomas.
    Sugimura T; Okabe K; Nagao M
    Cancer Res; 1966 Aug; 26(8):1717-21. PubMed ID: 4288552
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzymatic activation of the carcinogen 4-hydroxyaminoquinoline-1-oxide and its interaction with cellular macromolecules.
    Tada M; Tada M
    Biochem Biophys Res Commun; 1972 Jan; 46(2):1025-32. PubMed ID: 4333412
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of 4-nitroquinoline 1-oxide. II. In vivo conversion of subcutaneously injected 4-nitroquinoline 1-oxide to 4-aminoquinoline 1-oxide and 4-hydroxyquinoline 1-oxide in rats.
    Hoshino H; Fukuoka F; Okabe K; Sugimura T
    Gan; 1966 Feb; 57(1):71-4. PubMed ID: 5956663
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical binding of carcinogenic 4-nitroquinoline 1-oxide derivatives with DNA in vivo and in vitro.
    Kawazoe Y; Huang GF; Araki M; Koga C
    Gan; 1972 Apr; 63(2):161-6. PubMed ID: 5070235
    [No Abstract]   [Full Text] [Related]  

  • 6. Early events in in vitro carcinogenesis with 4-nitroquinoline 1-oxide. II. Mode of incorporation and binding of the carcinogen.
    Kuroki T; Kanamaru R; Sato H
    Gan; 1970 Aug; 61(4):373-82. PubMed ID: 5454685
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of 4-nitroquinoline 1-oxide. IV. Quantitative determination of in vivo conversion of 4-nitroquinoline 1-oxide in subcutaneous tissue of rat.
    Matsushima T; Kobuna I; Fukuoka F; Sugimura T
    Gan; 1968 Jun; 59(3):247-50. PubMed ID: 5726266
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of a carcinogen, 4-nitroquinoline-1-oxide, with nucleic acids: chemical degradation of the adducts.
    Tada M; Tada M
    Chem Biol Interact; 1971 Jun; 3(3):225-9. PubMed ID: 4332507
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on chemical carcinogens. XI. Metabolism of tritiated carcinogenic 4-nitroquinoline 1-oxide and distribution of its metabolites in the mouse.
    Kawazoe Y; Uehara N; Araki M; Tamura M
    Gan; 1969 Dec; 60(6):617-26. PubMed ID: 5368341
    [No Abstract]   [Full Text] [Related]  

  • 10. Elimination, tissue accumulation, and metabolic fate of 4-nitroquinoline 1-oxide administered orally in rats.
    Kato R; Takahashi A; Ngamwatana W; Omori Y
    Gan; 1970 Oct; 61(5):415-24. PubMed ID: 5476835
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakage of a DNA-protein complex induced by 4-nitroquinoline 1-oxide, 4-nitropyridine 1-oxide, and their derivatives in cultured mouse fibroblasts.
    Andoh T; Ide T; Saito M; Kawazoe Y
    Cancer Res; 1975 Mar; 35(3):521-7. PubMed ID: 1167806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory action of 4-nitroquinoline-N-oxide on the permeation and assimilation of nucleoside into mammalian cells.
    Pan IH
    Taiwan Yi Xue Hui Za Zhi; 1967 Jan; 66(1):17-26. PubMed ID: 5238893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current topics concerning a carcinogen, 4-nitroquinoline 1-oxide].
    Mita T; Kawazoe T
    Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):474-84. PubMed ID: 4913825
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of N-methyl-N'-nitro-N-nitrosoguanidine with ascites hepatoma cells in vitro.
    Nagao M; Yokoshima T; Hosoi H; Sugimura T
    Biochim Biophys Acta; 1969 Nov; 192(2):191-9. PubMed ID: 4313072
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation between carcinogenicity and metabolic reduction of 4-nitroquinoline 1-oxide derivatives.
    Araki M; Matsushima T; Sugimura T
    Experientia; 1970 May; 26(5):528-9. PubMed ID: 4315528
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolites of quinoline, a hepatocarcinogen, in a subcellular microsomal system.
    Tada M; Takahashi K; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3834-7. PubMed ID: 7160026
    [No Abstract]   [Full Text] [Related]  

  • 18. Free radical induced in rat liver by a chemical carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine.
    Nagata C; Ioki Y; Kodama M; Tagashira Y; Nakadate M
    Ann N Y Acad Sci; 1973 Dec; 222():1031-47. PubMed ID: 4361846
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenesis in tissue culture. 19. Photodynamic action of 4-nitroquinoline 1-oxide (4NQO) on mammalian cells in culture.
    Katsuta H; Takaoka T
    Jpn J Exp Med; 1972 Aug; 42(4):341-54. PubMed ID: 4341687
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of partial hepatectomy of rats on the metabolism of formate-C 14 in vivo by host liver and Morris hepatoma 5123-C.
    Wheeler GP; Alexander JA; Hill DD; Morris HP
    J Natl Cancer Inst; 1966 Apr; 36(4):709-15. PubMed ID: 4286939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.